The latest from Sheryl Pharmaceuticals - product launches, industry developments, company milestones and healthcare insights.
July 2026 · 3 min read
We are proud to announce the expansion of our Women's Healthcare segment with the addition of new specialty formulations addressing key unmet needs in women's reproductive and general health. These products have been developed in partnership with our GMP-certified manufacturing partners and reflect our commitment to advancing patient outcomes.
Read Full ArticleWe have entered into strategic distribution agreements with key partners across the South East Asian and Middle Eastern markets, significantly expanding our international footprint.
Read More ?Sheryl Pharmaceuticals has successfully onboarded a new WHO-GMP certified manufacturing partner, enhancing our production capacity and product range.
Read More ?Our Nutrition & Wellness segment sees fresh additions including omega-3 complexes, probiotic formulations and immunity-focused nutraceuticals.
Read More ?Sheryl Pharmaceuticals expands its anti-infective portfolio with clinically relevant antibiotic and antifungal combinations for both community and hospital settings.
Read More ?As we continue to grow, we are excited to share our progress, new appointments and the milestones we have achieved in our journey to become a trusted pharmaceutical partner.
Read More ?Our gastroenterology product range is reinforced with new probiotic and gut health formulations designed to address the growing burden of digestive disorders.
Read More ?